| Annualized Returns: | 117.61% | Average Win Size: | 3,365.59 |
| Maximum Drawdown: | 16.52% | Average Loss Size: | 2,170.02 |
| Return over Maximum Drawdown: | 7.11 | Win/Loss Size Ratio: | 1.55 |
| Sharpe Ratio (Annualized): | 2.72 | Number of Closed and Open Positions: | 2310 |
| Sortino Ratio (Annualized): | -4.04 | Average Trade Value: | 34,275 USD |
| Number of Wins: | 1218 | Average Closed Trade Duration: | 7.0 days |
| Number of Losses: | 1092 | Last Session Move: | -5,868.50 (-0.31%), Baseline move: (0.70%) |
| Win/Loss Count Ratio: | 1.12 (53% winners) | Win Months(%) | 88.4% |
| Includes 10 open positions with cash holdings of 1,064,392.82 USD Cash holdings are equivalent to 58% of Total Strategy Value (1,834,645.82 USD) at this time. |
|||
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 31.7 | -0.1 | 22.2 | 24.1 | 25.5 | 9.2 | 12.8 | -6.3 | 4.5 | 0.1 | 14.7 | 15.2 | 153.6 |
| 2024 | 17 | 15.5 | 4.5 | -2.1 | 3.2 | 1.5 | 5.5 | 3.5 | 0.7 | 4 | 6.6 | 1.2 | 61.1 |
| 2025 | 1.7 | 2.4 | 0.4 | 3.2 | 0.6 | 6.4 | 4 | 4.5 | 8.8 | 0.6 | 2.8 | -0.1 | 35.3 |
| 2026 | 1.5 | 7 | 1.4 | 9.5 | 14.5 | 11 | -2.7 | 0 | 0 | 0 | 0 | 0 | 42.2 |
| Symbol | Name | Entry Date | # Shares | Entry Price | Present Price | Move | Max Move | Days Held | Price | Trailing Stop | Profit | Annualized |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNDM | Tandem Diabetes Care | 2026-07-21 | 4600 | 17.62 | 19.50 | 10.66% | 10.66% | 9 | 18.56 (4.8%) | 8,648.00 | 284.5% | |
| ORIC | Oric Pharmaceuticals | 2026-07-27 | 5300 | 12.11 | 11.07 | -8.58% | 0.00% | 5 | 10.919 (1.4%) | -5,512.00 | -412.2% | |
| HALO | Halozyme Therapeutics | 2026-07-27 | 700 | 82.41 | 82.54 | 0.15% | 1.26% | 5 | 80.518 (2.4%) | 91.00 | 7.5% | |
| PCRX | Pacira BioSciences | 2026-07-28 | 2400 | 26.78 | 26.41 | -1.38% | 0.70% | 4 | 25.532 (3.3%) | -888.00 | -82.9% | |
| BMRN | BioMarin Pharmaceutical | 2026-07-28 | 1000 | 61.00 | 60.02 | -1.60% | 1.75% | 4 | 59.014 (1.7%) | -980.00 | -96.3% | |
| BBIO | BridgeBio Pharma | 2026-07-29 | 900 | 85.49 | 80.09 | -6.31% | 0.07% | 3 | 76.635 (4.3%) | -4,860.00 | -505.3% | |
| ADIL | Adial Pharmaceuticals | 2026-07-30 | 25800 | 3.14 | 3.34 | 6.36% | 6.36% | 2 | 2.821 (15.5%) | 5,160.00 | 764.3% | |
| ANIK | Anika Therapeutics Inc. | 2026-07-31 | 5300 | 18.33 | 19.28 | 5.18% | 5.18% | 1 | 17.332 (10.1%) | 5,035.00 | 1,243.8% | |
| CORT | Corcept Therapeutics Incorporat | 2026-07-31 | 800 | 118.11 | 114.49 | -3.06% | 0.17% | 1 | 97.942 (14.5%) | -2,896.00 | -735.5% | |
| REGN | Regeneron Pharmaceuticals | 2026-07-31 | 100 | 726.69 | 762.63 | 4.94% | 4.94% | 1 | 710.845 (6.8%) | 3,594.00 | 1,186.9% | |
| Total Value (USD) of 10 Open Positions: | 757,845.00 | 7,392.00 | 39.9% | |||||||||
| Symbol | Name | # Shares | Buy Date | Buy Price | Sell Date | Sell Price | Max Move | Duration | Price | Profit | ROI |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | 5200 | 2026-06-17 | 15.57 | 2026-07-01 | 18.10 | 19.78% | 10 | 13,156.00 | 16.2% | |
| AGIO | Agios Pharmaceuticals | 2300 | 2026-06-22 | 34.30 | 2026-07-01 | 37.08 | 11.69% | 8 | 6,394.00 | 8.1% | |
| RLAY | Relay Therapeutics | 4800 | 2026-06-23 | 16.65 | 2026-07-01 | 18.43 | 18.55% | 7 | 8,544.00 | 10.7% | |
| MGTX | MeiraGTx | 5400 | 2026-06-24 | 11.96 | 2026-07-01 | 13.08 | 12.95% | 6 | 6,048.00 | 9.4% | |
| VKTX | Viking Therapeutics | 1800 | 2026-06-24 | 35.63 | 2026-07-01 | 38.21 | 10.97% | 6 | 4,644.00 | 7.2% | |
| DFTX | Definium Therapeutics, Inc. | 1500 | 2026-06-25 | 41.99 | 2026-07-01 | 45.18 | 12.02% | 5 | 4,785.00 | 7.6% | |
| RVMD | Revolution Medicines | 300 | 2026-06-26 | 175.19 | 2026-07-01 | 187.51 | 9.94% | 4 | 3,696.00 | 7% | |
| ORKA | Oruka Therapeutics, Inc. | 900 | 2026-06-23 | 84.01 | 2026-07-02 | 90.84 | 13.28% | 8 | 6,147.00 | 8.1% | |
| DNLI | Denali Therapeutics | 3600 | 2026-06-16 | 22.12 | 2026-07-06 | 25.77 | 18.58% | 13 | 13,140.00 | 16.5% | |
| MPLT | MapLight Therapeutics, Inc. | 2200 | 2026-07-01 | 35.48 | 2026-07-06 | 36.29 | 4.53% | 3 | 1,782.00 | 2.3% | |
| MNPR | Monopar Therapeutics Inc. | 700 | 2026-06-24 | 82.04 | 2026-07-07 | 96.17 | 19.85% | 9 | 9,891.00 | 17.2% | |
| GH | Guardant Health | 400 | 2026-06-30 | 151.92 | 2026-07-07 | 165.48 | 14.58% | 5 | 5,424.00 | 8.9% | |
| MRNA | Moderna | 1200 | 2026-06-18 | 63.96 | 2026-07-08 | 76.84 | 28.36% | 13 | 15,456.00 | 20.1% | |
| NUVB | Nuvation Bio | 11500 | 2026-06-25 | 5.62 | 2026-07-08 | 5.87 | 14.94% | 9 | 2,875.00 | 4.4% | |
| TXG | 10X Genomics | 2100 | 2026-07-01 | 38.54 | 2026-07-08 | 37.47 | 3.78% | 5 | -2,247.00 | -2.8% | |
| RARE | Ultragenyx Pharmaceutical | 2400 | 2026-07-01 | 33.13 | 2026-07-08 | 34.96 | 8.27% | 5 | 4,392.00 | 5.5% | |
| ALDX | Aldeyra Therapeutics, Inc. | 33700 | 2026-07-02 | 2.41 | 2026-07-08 | 2.18 | 0.82% | 4 | -7,751.00 | -9.5% | |
| CLDX | Celldex Therapeutics | 2400 | 2026-06-18 | 33.69 | 2026-07-10 | 39.11 | 18.52% | 15 | 13,008.00 | 16.1% | |
| PTGX | Protagonist Therapeutics | 500 | 2026-06-24 | 119.38 | 2026-07-10 | 134.27 | 17.98% | 12 | 7,445.00 | 12.5% | |
| CORT | Corcept Therapeutics Incorporat | 700 | 2026-06-30 | 87.61 | 2026-07-10 | 92.27 | 7.33% | 8 | 3,262.00 | 5.3% | |
| ABSI | Absci Corporation | 5700 | 2026-06-30 | 11.34 | 2026-07-10 | 10.99 | 4.49% | 8 | -1,995.00 | -3.1% | |
| ZVRA | Zevra Therapeutics, Inc. | 5600 | 2026-07-01 | 14.31 | 2026-07-10 | 13.94 | 3.07% | 7 | -2,072.00 | -2.6% | |
| FHTX | Foghorn Therapeutics Inc. | 15400 | 2026-07-06 | 5.27 | 2026-07-10 | 5.95 | 17.07% | 5 | 10,472.00 | 12.9% | |
| VRTX | Vertex Pharmaceuticals Incorporated | 100 | 2026-07-07 | 530.00 | 2026-07-10 | 491.77 | 0.00% | 4 | -3,823.00 | -7.2% | |
| ARWR | Arrowhead Pharmaceuticals | 900 | 2026-07-07 | 87.28 | 2026-07-10 | 80.44 | 0.00% | 4 | -6,156.00 | -7.8% | |
| ORIC | Oric Pharmaceuticals | 6900 | 2026-07-06 | 11.64 | 2026-07-13 | 10.62 | 0.00% | 6 | -7,038.00 | -8.8% | |
| ADUS | Addus placeholder | 700 | 2026-07-06 | 105.16 | 2026-07-13 | 108.86 | 8.79% | 6 | 2,590.00 | 3.5% | |
| BCAX | Bicara Therapeutics Inc. | 2700 | 2026-07-07 | 29.45 | 2026-07-13 | 28.34 | 3.22% | 5 | -2,997.00 | -3.8% | |
| TRVI | Trevi Therapeutics, Inc. | 3300 | 2026-07-08 | 19.51 | 2026-07-13 | 17.56 | 0.00% | 4 | -6,435.00 | -10% | |
| MGTX | MeiraGTx | 4500 | 2026-07-08 | 14.44 | 2026-07-13 | 13.00 | 1.52% | 4 | -6,480.00 | -10% | |
| RCKT | Rocket Pharmaceuticals | 15500 | 2026-07-09 | 4.17 | 2026-07-13 | 3.78 | 1.67% | 3 | -6,045.00 | -9.4% | |
| VVOS | Vivos Therapeutics, Inc. | 101908.701855 | 2025-07-10 | 0.701 | 2026-07-13 | 0.525 | 1,204.34% | 253 | -17,935.93 | -25.1% | |
| LRMR | Larimar Therapeutics, Inc. | 19300 | 2026-07-13 | 4.19 | 2026-07-14 | 3.77 | 2.14% | 2 | -8,106.00 | -10% | |
| NUVL | Nuvalent | 700 | 2026-07-14 | 123.97 | 2026-07-14 | 123.96 | 0.00% | 1 | -7.00 | 0% | |
| ADUS | Addus placeholder | 700 | 2026-07-17 | 112.89 | 2026-07-14 | 117.28 | 5.60% | 1 | 3,073.00 | 3.9% | |
| CORT | Corcept Therapeutics Incorporat | 600 | 2026-07-22 | 95.18 | 2026-07-14 | 118.32 | 24.31% | 1 | 13,884.00 | 24.3% | |
| INCY | Incyte | 500 | 2026-07-28 | 119.00 | 2026-07-14 | 123.49 | 9.18% | 1 | 2,245.00 | 3.8% | |
| FATE | Fate Therapeutics | 26800 | 2026-07-02 | 3.02 | 2026-07-15 | 2.99 | 2.98% | 9 | -804.00 | -1% | |
| ILMN | Illumina | 400 | 2026-07-07 | 193.92 | 2026-07-15 | 189.30 | 0.21% | 7 | -1,848.00 | -2.4% | |
| LGND | Ligand Pharmaceuticals | 200 | 2026-07-07 | 317.97 | 2026-07-15 | 299.13 | 1.33% | 7 | -3,768.00 | -5.9% | |
| ANAB | AnaptysBio | 1300 | 2026-07-14 | 70.91 | 2026-07-15 | 63.82 | 0.00% | 2 | -9,217.00 | -10% | |
| ACRS | Aclaris Therapeutics, Inc. | 14400 | 2026-07-06 | 5.63 | 2026-07-16 | 5.48 | 2.30% | 9 | -2,160.00 | -2.7% | |
| PSNL | Personalis | 6400 | 2026-07-14 | 15.14 | 2026-07-16 | 15.58 | 4.29% | 3 | 2,816.00 | 2.9% | |
| TTRX | Turn Therapeutics Inc. | 6800 | 2026-07-08 | 9.43 | 2026-07-17 | 9.12 | 3.28% | 8 | -2,108.00 | -3.3% | |
| JSPR | Jasper Therapeutics, Inc. | 112800 | 2026-07-15 | 0.72 | 2026-07-17 | 0.885 | 22.91% | 3 | 18,612.00 | 22.9% | |
| VYNE | VYNE Therapeutics Inc. | 113600 | 2026-07-15 | 0.715 | 2026-07-17 | 0.76 | 7.41% | 3 | 5,112.00 | 6.3% | |
| DFTX | Definium Therapeutics, Inc. | 1300 | 2026-07-09 | 47.73 | 2026-07-20 | 43.32 | 0.00% | 8 | -5,733.00 | -9.2% | |
| AKBA | Akebia Therapeutics | 45400 | 2026-07-09 | 1.43 | 2026-07-20 | 1.31 | 0.00% | 8 | -5,448.00 | -8.4% | |
| ABEO | Abeona Therapeutics Inc. | 13800 | 2026-07-14 | 7.05 | 2026-07-20 | 6.75 | 3.40% | 5 | -4,140.00 | -4.3% | |
| COR | Cencora, Inc. | 200 | 2026-07-09 | 301.52 | 2026-07-21 | 303.07 | 2.66% | 9 | 310.00 | 0.5% | |
| CYRX | CryoPort, Inc. | 4900 | 2026-07-16 | 16.38 | 2026-07-21 | 16.24 | 1.15% | 4 | -686.00 | -0.9% | |
| TMO | Thermo Fisher Scientific Inc | 100 | 2026-07-17 | 539.10 | 2026-07-21 | 523.46 | 0.75% | 3 | -1,564.00 | -2.9% | |
| INMB | INmune Bio | 39000 | 2026-07-15 | 2.08 | 2026-07-22 | 1.91 | 0.00% | 6 | -6,630.00 | -8.2% | |
| SION | Sionna Therapeutics, Inc. | 1200 | 2026-07-20 | 50.20 | 2026-07-22 | 45.98 | 0.00% | 3 | -5,064.00 | -8.4% | |
| MNPR | Monopar Therapeutics Inc. | 700 | 2026-07-13 | 106.15 | 2026-07-23 | 109.32 | 6.99% | 9 | 2,219.00 | 3% | |
| DNTH | Dianthus Therapeutics, Inc. | 900 | 2026-07-14 | 99.85 | 2026-07-23 | 104.79 | 5.87% | 8 | 4,446.00 | 4.9% | |
| TRVI | Trevi Therapeutics, Inc. | 3300 | 2026-07-20 | 19.28 | 2026-07-23 | 17.35 | 0.00% | 4 | -6,369.00 | -10% | |
| VYNE | VYNE Therapeutics Inc. | 74200 | 2026-07-23 | 0.875 | 2026-07-24 | 0.655 | 5.48% | 2 | -16,324.00 | -25.1% | |
| TXG | 10X Genomics | 1700 | 2026-07-15 | 45.81 | 2026-07-27 | 46.14 | 5.95% | 9 | 561.00 | 0.7% | |
| BLFS | BioLife Solutions, Inc. | 2700 | 2026-07-17 | 30.00 | 2026-07-27 | 29.83 | 3.86% | 7 | -459.00 | -0.6% | |
| APGE | Apogee Therapeutics, Inc. | 400 | 2026-07-08 | 133.52 | 2026-07-28 | 134.25 | 0.59% | 15 | 292.00 | 0.5% | |
| SYRE | Spyre Therapeutics, Inc. | 700 | 2026-07-16 | 103.32 | 2026-07-28 | 99.96 | 0.00% | 9 | -2,352.00 | -3.3% | |
| IMCR | Immunocore | 1800 | 2026-07-20 | 34.75 | 2026-07-28 | 33.65 | 2.27% | 7 | -1,980.00 | -3.2% | |
| BBNX | Beta Bionics, Inc. | 4600 | 2026-07-21 | 17.56 | 2026-07-28 | 16.05 | 1.48% | 6 | -6,946.00 | -8.6% | |
| XNCR | Xencor | 4300 | 2026-07-21 | 18.85 | 2026-07-28 | 19.97 | 9.17% | 6 | 4,816.00 | 5.9% | |
| IOVA | Iovance Biotherapeutics | 16000 | 2026-07-21 | 5.07 | 2026-07-28 | 4.84 | 8.48% | 6 | -3,680.00 | -4.5% | |
| BTMD | Biotricity | 32700 | 2026-07-21 | 2.48 | 2026-07-28 | 2.29 | 2.01% | 6 | -6,213.00 | -7.7% | |
| DYN | Dyne Therapeutics | 3400 | 2026-07-16 | 23.84 | 2026-07-29 | 25.53 | 8.89% | 10 | 5,746.00 | 7.1% | |
| NVO | Novo Nordisk A/S | 1500 | 2026-07-17 | 51.06 | 2026-07-31 | 47.40 | 1.07% | 11 | -5,490.00 | -7.2% | |
| NUVB | Nuvation Bio | 10100 | 2026-07-23 | 6.42 | 2026-07-31 | 6.51 | 4.36% | 7 | 909.00 | 1.4% | |
| LQDA | Liquidia Corporation | 700 | 2026-07-23 | 86.22 | 2026-07-31 | 85.18 | 4.91% | 7 | -728.00 | -1.2% | |
| RPRX | Royalty Pharma plc | 1100 | 2026-07-23 | 58.68 | 2026-07-31 | 58.53 | 2.19% | 7 | -165.00 | -0.3% | |
| NBIX | Neurocrine Biosciences | 300 | 2026-07-27 | 176.46 | 2026-07-31 | 176.17 | 5.12% | 5 | -87.00 | -0.2% |
| Month-To-Date Summary: | |
|---|---|
| MTD Win Trades %: | 47.9% |
| MTD Avg # Entry Trades per Day: | 2.5 |
| MTD Avg # Positions Held: | 16.1 |
| MTD Win/Loss Size Ratio: | 1.26 |
| MTD Avg Trade Duration: | 9.6 |
| MTD Strategy Performance: | -3.7% |
| MTD Baseline (^GSPC) Performance: | -0.1% |
| MTD Strategy Outperformance compared to Baseline: | -3.6% |
| Sold Today: | NVO, NUVB, LQDA, RPRX, NBIX |
| Pending Buys: | ILMN, QNCX |
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's position, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Investors should consider the investment objectives, risks, and charges and expenses of the above system carefully before investing.
Last Session Date: 2026/07/31